ClinicalTrials.gg
Active, not recruitingNCT07925736ALAS PROPIASUpdated Nov 9, 2026

ALAS PROPIAS: BMGIM for Professionals Working in Intimate Partner Machista Violence Services

An interventional study of ALAS PROPIAS - Individual Music Therapy BMGIM in Burnout Syndrome and Psychological Well-being, sponsored by Universidad Miguel Hernandez de Elche. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Universidad Miguel Hernandez de Elche · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2026, registered Nov 2026).
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the impact of a 10-session individual music therapy intervention using the Bonny Method of Guided Imagery and Music (BMGIM) on the well-being and psychological health of professionals working in services supporting women experiencing intimate partner machista violence.

The study uses a controlled, non-randomized quasi-experimental design, with an experimental group and a wait-list control group. Changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed.

Read the detailed description

Professionals working in services supporting women experiencing intimate partner machista violence may experience psychological consequences associated with continued exposure to others' traumatic experiences, including burnout, compassion fatigue, vicarious trauma, and secondary traumatic stress.

This study examines the impact of an individual music therapy intervention based on the Bonny Method of Guided Imagery and Music (BMGIM), consisting of 10 individual sessions. Using a controlled, non-randomized quasi-experimental design, outcomes in the experimental group are compared with those in a wait-list control group.

Changes in vicarious trauma and secondary traumatic stress, burnout, compassion fatigue, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed. The study aims to contribute scientific evidence on the potential of BMGIM music therapy to support the well-being and psychological health of professionals working in contexts of intimate partner machista violence.

02

Conditions studied

  • Burnout Syndrome
  • Psychological Well-being

Keywords

  • Music Therapy
  • BMGIM
  • Burnout
  • Compassion Fatigue
  • Vicarious Trauma
  • Secondary Traumatic Stress
  • Intimate Partner Violence
  • Machista violence
03

In context

Burnout, Psychological

467 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

This study's enrollment of 54 is below the median of 80 across 343 interventional studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

Universidad Miguel Hernandez de Elche is the lead sponsor of 87 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Professionals working in centers or shelters supporting women experiencing intimate partner machista violence.
  • Direct professional contact with cases of intimate partner violence.
  • Interest in participating in the individual BMGIM intervention and provision of .

Exclusion criteria

Exclusion Criteria:

  • Active psychosis.
  • Unstabilized suicidal crisis.
  • Uncontrolled substance use that prevents participation.
  • Inability to attend weekly sessions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Individual BMGIM Music Therapy

    Participants receive 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM).

    Behavioral: ALAS PROPIAS - Individual Music Therapy BMGIM

  • No intervention
    Control Group (Wait-List)

    Participants complete the same assessments as the experimental group during the initial study period but do not receive the intervention during this phase. The intervention may be offered after the initial data collection, in accordance with the study protocol.

Interventions

  • BehavioralALAS PROPIAS - Individual Music Therapy BMGIM

    The ALAS PROPIAS intervention consists of 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM), aimed at professionals working in services supporting women experiencing machista violence in intimate partner relationship. The intervention focuses on exploring imagery, emotions, and sensations through guided music listening, followed by a process of integration and reflection. The program aims to evaluate changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, psychological well-being, and professional well-being among participants.

06

What researchers measure

Primary outcomes

  1. Change in Burnout

    Burnout will be assessed using the Spanish adaptation of the Maslach Burnout Inventory (MBI) (Maslach \& Jackson, 1981; Seisdedos, 1997). Scores at the final assessment will be compared with baseline scores to evaluate changes in burnout among participants in the experimental and wait-list control groups.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  2. Change in Positive and Negative Affect

    Positive and negative affect will be assessed using the Spanish adaptation of the Positive and Negative Affect Schedule (PANAS) (Sandín et al., 1999). Scores at the final assessment will be compared with baseline scores to evaluate changes in positive and negative affect in the experimental and wait-list control groups.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  3. Change in Psychological Well-Being

    Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in the experimental and wait-list control groups.

    Time frame: Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in

  4. Change in Professional Quality of Life

    Professional quality of life will be assessed using the Spanish adaptation of the Professional Quality of Life Scale, version 5 (ProQOL-5) (Galiana et al., 2020). Scores at the final assessment will be compared with baseline scores to evaluate changes in professional quality of life in the experimental and wait-list control groups.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  5. Change in Secondary Traumatic Stress

    Secondary traumatic stress will be assessed using the Secondary Traumatic Stress Scale (STSS) (Guerra \& Saiz, 2007). Scores at the final assessment will be compared with baseline scores to evaluate changes in secondary traumatic stress in the experimental and wait-list control groups.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the primary and secondary outcomes will be made available to qualified researchers upon reasonable request submitted to the principal investigator. Data sharing will be subject to ethical review, a formal data-sharing agreement, and strict compliance with European Union GDPR regulations to safeguard minor participants' confidentiality.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will become available after the primary manuscript publishing the final longitudinal findings is accepted

Access criteria: Individual participant data will not be publicly shared to protect minor participants' confidentiality in compliance with GDPR and local data protection regulations. Aggregate data and protocol materials are available upon request

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925736
Lead sponsor
Universidad Miguel Hernandez de Elche
Responsible party
Eva Maria Leon Zarceño (Associate Professor, Universidad Miguel Hernandez de Elche) — Principal investigator
First posted
Nov 9, 2026
Start date
Apr 21, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Nov 9, 2026

Study contacts

Eva Maria León Zarceño
principal investigator · Universidad Miguel Hernández de Elche.
Vicente Alejandro March Luján
principal investigator · Catholic University of Valencia
Marie Laure Rodríguez-Quiroga
principal investigator · Universidad Miguel Hernández de Elche.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion